Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline in a transgenic rat model displaying Alzheimer-like amyloid pathology
Chiara Orciani, Sonia Do Carmo, Morgan K. Foret, Hélène Hall, Quentin Bonomo, Agustina Lavagna, Chunwei Huang, A. Claudio Cuello
Topics & Concepts
AgonistHippocampal formationHippocampusEndocrinologyInternal medicineAstrogliosisMicrogliaMedicineAlzheimer's diseaseCognitive declineNeurotrophic factorsGliosisNeuroscienceReceptorPharmacologyPsychologyDementiaDiseaseCentral nervous systemInflammationPharmacological Receptor Mechanisms and EffectsNeuropeptides and Animal PhysiologyReceptor Mechanisms and Signaling